ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628561; 2) Community: the network communities that were significantly associated with the response to NSC 628561; 3) Molecule: the relationships between components within communities and NSC 628561; 4) MDR: the compounds that were significantly associated with the NSC 628561.

NSC Compound Enrichment Correlation
NSC 681229 Boronic acid, [1-[[2-amino-3-(1-naphthalenyl)- 1-oxopropyl]amino]-3-methylbutyl]-, L-(S)-, hydrochloride 0.0467178916101838 0.37584599
NSC 681637 Camptothecin Derivative 0.0467178916101838 0.11425988
NSC 682864 Null 0.0467178916101838 0.18518526
NSC 683260 Null 0.0467178916101838 0.3966016
NSC 685126 4-Piperidinone, 3,5-bis[(4-fluorophenyl)methylene]-, (E,E)- 0.0467178916101838 0.19973663
NSC 689176 Null 0.0467178916101838 0.21431763
NSC 690271 ANTINEOPLASTIC-690271 0.0467178916101838 0.39247702
NSC 696885 Null 0.0467178916101838 0.19918346
NSC 699471 Null 0.0467178916101838 0.20346323
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0467178916101838 0.19661605
Total:91  Current:80    [First] [Prev] [Next] [Last]